Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound. Disclaimer

LimitlessLab
Search the library Wishlist Cart, items: 0
NAD+

Non-peptide Adjuncts

NAD+

Also known as Nicotinamide adenine dinucleotide; precursors: NMN, NR (Niagen)

Limited human evidenceCosmetic or supplementNot a peptide

Price range: €72 through €135

Discussed for: Cellular energy, anti-aging drips.

Sequence: not listed. Modified or non-standard residues are left out on purpose.

Effect strengthHow hard it acts on the body3/10
Proof levelHow well that is shown in humans4/10
Risk levelHow much can go wrong2/10

Editorial 1 to 10 estimates from published research, not measured values. How to read these

Save to wishlist
Save to wishlist

01 / Identity

What it is

NAD+ is a coenzyme, not a peptide. Main reported uses: cellular energy, anti-aging drips. Current status: not approved as a drug; precursors sold as supplements (NMN's US supplement status is disputed).

Molecule type
Coenzyme, not a peptide
How it is taken
IV drip, injection (SC), oral precursors
Other names
Nicotinamide adenine dinucleotide; precursors: NMN, NR (Niagen)

Route only. This library does not publish doses or protocols.

02 / Mechanism

How it is thought to work

Coenzyme used by mitochondria for energy production and by sirtuin/DNA-repair enzymes

Mechanisms seen in cells or animals do not always happen the same way in people.

03 / Potential benefits

What people use it for

Cellular energy, anti-aging drips

Limited human evidence

Small or low-quality human data. Most of what is claimed comes from animals, cells or anecdotes.

Listed uses are what people use it for, not proven outcomes.

04 / Known risks

Side effects and risks

Flushing, nausea and chest pressure during fast IV infusion

Risk level 2 of 10

Lower risk score: reported side effects are mostly mild. Low risk is not no risk, especially for unregulated products.

Unknown long-term effects count as a risk, not as a clean record.

05 / Regulatory

Regulatory status

Status
Cosmetic or supplement
Details
Not approved as a drug; precursors sold as supplements (NMN's US supplement status is disputed)
Sport (WADA)
Not listed

Status reflects information up to mid-2026 and changes over time. Check current sources.

06 / Evidence quality

How good is the evidence?

Limited: small human trials of precursors, mixed results

How we grade evidence

07 / Notes and sources

Notes and sources

  • Not technically a peptide. It is listed because it is often sold or discussed alongside peptides.
  • Talk to a pharmacist or doctor before combining supplements with medicines.
  • Source: Peptide Reference Table, an editorial review of published research up to mid-2026. Scores are 1 to 10 editorial estimates, not measured values. Regulatory and WADA status change over time.

Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound.

Related compounds